Simplified marketing authorisation renewal process for pharmaceutical products in Vietnam
in VietnamTrade barrier summary
Vietnam has issued the Marketing Authorisation Renewal Decree, which marks a significant milestone for the pharmaceutical sector. It provides a more sustainable mechanism to ensure the continued availability of medicines on the market for patient access. This applies to both imported medicines and those produced locally.
As a result, UK businesses will benefit from reduced complexity during the marketing authorisation renewal process. Pending marketing authorisation renewal dossiers that were submitted before 31 December 2024 will have automatic validity – UK businesses do not need to submit or resubmit any document.
Sectors affected
- Pharmaceuticals and biotechnology
Resolved
Yes - January 2025
Date reported
27 May 2020
Last updated
1 December 2025
Public ID
PID-YB8AAB
If a trade barrier is affecting your exports or investment from the UK, please let us know on report a trade barrier .
If you export goods you can check duties and customs procedures for your chosen market.